Complex comprising water-soluble beta blocker and lecithin
The present invention addresses the problem of providing an external pharmaceutical composition imparting an excellent balance of light stability, transdermal absorbability, and skin retention to a beta blocker (particularly propranolol hydrochloride), and provides a complex comprising a water-solub...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention addresses the problem of providing an external pharmaceutical composition imparting an excellent balance of light stability, transdermal absorbability, and skin retention to a beta blocker (particularly propranolol hydrochloride), and provides a complex comprising a water-soluble beta blocker and lecithin, a method for producing the complex, an external pharmaceutical composition containing the complex, and the like. When the complex or an oil-in-oil dispersion containing the complex is applied to a conventional pharmaceutical external preparation prescription (for example, a W/O type cream), the complex containing a beta blocker is caused to be present in the O phase, thereby avoiding contact with water and dissolved oxygen and reducing the risk of photolysis.
本发明的课题为提供对β阻断剂(特别是普萘洛尔盐酸盐)赋予光稳定性,经皮吸收性及皮肤滞留性的平衡优异的外用医药组合物,提供由水溶性β阻断剂及卵磷脂形成的复合体、制造该复合体的方法、包含该复合体的外用医药组合物等。将该复合体、或包含该复合体的油中分散液应用于现有的医药外用剂处方(例如,W/O型的霜),通过使包含β阻断剂的复合体存在于O相,从而避免与水、溶解氧的接触,降低光分解的风险。 |
---|---|
Bibliography: | Application Number: CN202180078222 |